Table 1.

Characteristics of the study population according to the diagnosis of NAFLD

	No NAFLD (n = 20)	NAFLD (n = 32)	p valueb
Age (years)	42.13 ± 8.7	45.22 ± 10.9	0.35
Gender (F%)	87%	65%	0.03a
BMI (Kg/m2)	43.8 ± 6.1	42.1 ± 5.4	0.37
Waist circumference (cm)	128.1 ± 12.5	127.7 ± 16.1	0.94
PAS (mmHg)	129.2 ± 10.3	126.9 ± 11.8	0.47
PAD (mmHg)	84.2 ± 6.9	84.9 ± 17.4	0.86
AST (IU/l)	20.8 ± 7.8	29 ± 13.7	0.032
ALT (IU/l)	21.9 ± 10.4	41 ± 23.2	< 0.001
GGT (UI/l)	20.16 ± 7.2	30.8 ± 17.7	0.009
Total cholesterol (mg/dl)	204.7 ± 30.6	190.6 ± 29.6	0.15
HDL-C (mg/dl)	48.8 ± 11.3	45.4 ± 10.7	0.34
LDL-C (mg/dl)	131.6 ± 23.1	113.6 ± 26.6	0.03
Triglycerides (mg/dl)	109 ± 39	167.1 ± 74.5	0.006
Total bilirubin (mg/dl)	3.9 ± 6.7	2.25 ± 3.9	0.34
Direct bilirubin (mg/dl)	1.40 ± 2.84	0.92 ± 1.9	0.58
FBG (mg/dl)	96.8 ± 12.9	103.8 ± 23	0.23
HbA1c (%)	5.3 ± 0.3	5.7 ± 0.63	0.05
FBI (IU/mL)	11.9 ± 7	15.3 ± 8.2	0.29
HOMA-IR	2.85 ± 1.5	3.82 ± 2.4	0.24
HOMA-β%	149.6 ± 145.7	169.2 ± 70.5	0.69
FIB-4	0.8 ± 0.25	1.04 ± 0.3	0.039
Steatosis % [median(range)]	3.5 (0.75–5)	60 (30–70)	< 0.001
Steatosis grade (n, 0/1/2/3)	20/0/0/0	0/8/8/16	< 0.001
Lobular inflammation (n, 0/1/2)	8/12/0	14/8/10	0.10
Ballooning (n, 0/1/2)	19/1/0	12/15/5	< 0.001
Fibrosis (F0/F1/F2/F3/F4)	10/10/0/0/0	10/18/3/1/0	0.20

T test applied

^a${\chi }^2$ test applied

^bMann–Whitney test applied. Statistical significance is related to the comparison between NAFLD and non-NAFLD sub-groups